Brought to you by 
Transkaryotic Therapy completes 2.5mm share IPO, nets $35mm
13 Jul 1999
Executive Summary
Transkaryotic Therapies (gene therapy company, founded in 1988) was successful at its second attempt at an initial public offering (the first was in 1993), selling 2.5mm common shares at $15 each, and netting $35mm.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Transkaryotic Therapy completes 2.5mm share IPO, nets $35mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice